Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
MiR-21 regulates the ACAT1 gene in MCF-7 cells. / Chanyshev, M. D.; Razumova, Y. V.; Ovchinnikov, V. Y. и др.
в: Life Sciences, Том 209, 15.09.2018, стр. 173-178.Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование
}
TY - JOUR
T1 - MiR-21 regulates the ACAT1 gene in MCF-7 cells
AU - Chanyshev, M. D.
AU - Razumova, Y. V.
AU - Ovchinnikov, V. Y.
AU - Gulyaeva, L. F.
N1 - Copyright © 2018 Elsevier Inc. All rights reserved.
PY - 2018/9/15
Y1 - 2018/9/15
N2 - Aims: The purpose of the present study was to determine whether miR-21 regulates the human ACAT1 gene. We also assessed whether transfection of MCF-7 cells with miR-21 mimic/inhibitor leads to changes in ACAT1 mRNA/protein levels, cell proliferation rate, or apoptosis. Main methods: Regulation of ACAT1 3′UTR by miR-21 was evaluated using a dual-luciferase reporter assay. The effect of miR-21 on mRNA/protein levels of ACAT1 and PTEN (confirmed as an important target of miR-21 for comparison) was measured by qPCR/western blot analysis and immunostaining. Proliferation rate was determined by cell counting. Percentage of cells undergoing late apoptosis was determined by staining with Hoechst 33342/propidium iodide. Key findings: Dual-luciferase reporter assay confirmed the regulation of ACAT1 3′UTR by miR-21. Furthermore, transfection of MCF-7 cells with miR-21 mimic decreased mRNA and protein levels of ACAT1 and PTEN genes. In contrast, miR-21 inhibition increased the mRNA and protein levels of both genes studied. Finally, we observed an increase in cell proliferation and decrease in the percentage of cells in late apoptosis in MCF-7 cells transfected with miR-21 mimic, whereas transfection with miR-21 inhibitor led to the opposite effect. Significance: Our data confirm the hypothesis that miR-21 regulates the human ACAT1 gene. As the expression of this microRNA is altered in many types of cancers, the discovery of novel targets for miR-21 is of particular interest for diagnosis and treatment.
AB - Aims: The purpose of the present study was to determine whether miR-21 regulates the human ACAT1 gene. We also assessed whether transfection of MCF-7 cells with miR-21 mimic/inhibitor leads to changes in ACAT1 mRNA/protein levels, cell proliferation rate, or apoptosis. Main methods: Regulation of ACAT1 3′UTR by miR-21 was evaluated using a dual-luciferase reporter assay. The effect of miR-21 on mRNA/protein levels of ACAT1 and PTEN (confirmed as an important target of miR-21 for comparison) was measured by qPCR/western blot analysis and immunostaining. Proliferation rate was determined by cell counting. Percentage of cells undergoing late apoptosis was determined by staining with Hoechst 33342/propidium iodide. Key findings: Dual-luciferase reporter assay confirmed the regulation of ACAT1 3′UTR by miR-21. Furthermore, transfection of MCF-7 cells with miR-21 mimic decreased mRNA and protein levels of ACAT1 and PTEN genes. In contrast, miR-21 inhibition increased the mRNA and protein levels of both genes studied. Finally, we observed an increase in cell proliferation and decrease in the percentage of cells in late apoptosis in MCF-7 cells transfected with miR-21 mimic, whereas transfection with miR-21 inhibitor led to the opposite effect. Significance: Our data confirm the hypothesis that miR-21 regulates the human ACAT1 gene. As the expression of this microRNA is altered in many types of cancers, the discovery of novel targets for miR-21 is of particular interest for diagnosis and treatment.
KW - ACAT1
KW - Cancer
KW - MCF-7
KW - miR-21
KW - PTEN
KW - MicroRNAs/genetics
KW - Cell Proliferation
KW - Humans
KW - Gene Expression Regulation, Neoplastic
KW - Biomarkers, Tumor/genetics
KW - MCF-7 Cells
KW - Female
KW - Breast Neoplasms/genetics
KW - Tumor Cells, Cultured
KW - Acetyl-CoA C-Acetyltransferase/genetics
KW - Apoptosis
KW - Cell Movement
UR - http://www.scopus.com/inward/record.url?scp=85051111964&partnerID=8YFLogxK
U2 - 10.1016/j.lfs.2018.08.010
DO - 10.1016/j.lfs.2018.08.010
M3 - Article
C2 - 30092298
AN - SCOPUS:85051111964
VL - 209
SP - 173
EP - 178
JO - Life Sciences
JF - Life Sciences
SN - 0024-3205
ER -
ID: 16084312